Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States

Funding Opportunity Number: RFA-IP-16-002 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.185Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDC-HHSCDCERAClosing Date: Jan 11, 2016Award Ceiling: $1,000,000Expected Number of Awards: 5Creation Date: Nov 05, 2015Funding Opportunity Description: Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups. Because influenza viruses are constantly changing and vaccines are reformulated every year, annual estimates of the effectiveness of influenza vaccines in preventing influenza infection and its associated complications are needed in order to evaluate the protection provided by annual, nationwide vaccination programs. Each year in the United States, influenza viruses infect up to 20% of the population and cause hundreds of thousands to millions of medically-attended illnesses and thousands of hospitalizations and deaths. Annual influenza vaccination is the primary influenza prevention strategy and is recommended for all people ≥ 6 months of age in the U.S. Many studies have described the vaccine effectiveness (VE) of seasonal and 2009 pandemic influenza vaccine formulations against laboratory-confirmed symptomatic and medically-attended outpatient influenza illness (Griffin, 2011; Trea...
Source: Grants.gov - Category: Research Tags: Health Source Type: funding